We’re all unique
So is Aummune

Aummune develops a first-of-its-kind individual drug-customization platform that utilizes a unique efficacy-driven selection process to match and produce a patient-specific tri-functional aptamer drug that safely and synergistically induces cancer cell death and activates both innate and adaptive immune responses

Individually tailored tri-functional aptamers

Synergistic tumoricidal and immune effects

Constant Strand

Engages immune effector T
cells, leading to
tumor cell lysis.

Bridge

A CpG-rich domain that both fuses
the two strands and induces Antigen
Presenting Cells stimulation through
Toll-Like Receptor 9

Variable Strand

A tumor-targeting arm, selected for its
ability to bind the patient’s cancer cells
and induce cancer cell death while
avoiding effects on healthy tissue.

Tailoring the
variable strand
to every patient

Aummune’s platform utilizes a positive
and negative selection process on a
patient’s tumor and healthy cell samples,
to achieve a tumoricidal yet safe effect

Sample
processing

Efficacy-driven
selection

Personal
drug
assembly

Administration

Let's Connect

Tel Aviv Medical Center (TAMC),
Sammy Ofer Building, Floor 10
Weizmann St 6, Tel Aviv-Yafo, ISRAEL
info@aummune.tech